Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Libetta

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Seminars in Dialysis|November 17, 2015
Progressive Hemodialysis: Is It The Future?Carmelo Libetta, Peni Nissani, Antonio Dal Canton
International Reviews of Immunology|November 16, 2010
Bio-incompatibility and Th2 polarization during regular dialysis treatmentCarmelo Libetta, Vincenzo Sepe, Antonio Dal Canton
Journal of Nephrology|November 26, 2021
The innate immune system in human kidney inflammagingVincenzo Sepe, Carmelo Libetta, Marilena Gregorini, et al.
Clinical Biochemistry|July 23, 2011
Oxidative stress and inflammation: Implications in uremia and hemodialysisCarmelo Libetta, Vincenzo Sepe, Pasquale Esposito, et al.
Cell Stress & Chaperones|October 6, 2010
Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patientsPasquale Esposito, Carmine Tinelli, Carmelo Libetta, et al.
Biomed Research International|January 16, 2018
RBP4: A Culprit for Insulin Resistance in End Stage Renal Disease That Can Be Cleared by HemodiafiltrationFabrizio Grosjean, Pasquale Esposito, Rosario Maccarrone, et al.
Journal of Diabetes and Its Complications|September 22, 2015
Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitusGiuseppe Derosa, Carmelo Libetta, Pasquale Esposito, et al.
BMC Nephrology|November 16, 2019
Vitamin e-loaded membrane dialyzers reduce hemodialysis inflammagingVincenzo Sepe, Marilena Gregorini, Teresa Rampino, et al.
Cytokine|January 23, 2017
Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitusGiuseppe Derosa, Carmelo Libetta, Pasquale Esposito, et al.
Clinical and Experimental Nephrology|December 18, 2015
Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implicationsCarmelo Libetta, Pasquale Esposito, Claudia Martinelli, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Seminars in Dialysis|November 17, 2015
Progressive Hemodialysis: Is It The Future?Carmelo Libetta, Peni Nissani, Antonio Dal Canton
International Reviews of Immunology|November 16, 2010
Bio-incompatibility and Th2 polarization during regular dialysis treatmentCarmelo Libetta, Vincenzo Sepe, Antonio Dal Canton
Journal of Nephrology|November 26, 2021
The innate immune system in human kidney inflammagingVincenzo Sepe, Carmelo Libetta, Marilena Gregorini, et al.
Clinical Biochemistry|July 23, 2011
Oxidative stress and inflammation: Implications in uremia and hemodialysisCarmelo Libetta, Vincenzo Sepe, Pasquale Esposito, et al.
Cell Stress & Chaperones|October 6, 2010
Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patientsPasquale Esposito, Carmine Tinelli, Carmelo Libetta, et al.
Biomed Research International|January 16, 2018
RBP4: A Culprit for Insulin Resistance in End Stage Renal Disease That Can Be Cleared by HemodiafiltrationFabrizio Grosjean, Pasquale Esposito, Rosario Maccarrone, et al.
Journal of Diabetes and Its Complications|September 22, 2015
Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitusGiuseppe Derosa, Carmelo Libetta, Pasquale Esposito, et al.
BMC Nephrology|November 16, 2019
Vitamin e-loaded membrane dialyzers reduce hemodialysis inflammagingVincenzo Sepe, Marilena Gregorini, Teresa Rampino, et al.
Cytokine|January 23, 2017
Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitusGiuseppe Derosa, Carmelo Libetta, Pasquale Esposito, et al.
Clinical and Experimental Nephrology|December 18, 2015
Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implicationsCarmelo Libetta, Pasquale Esposito, Claudia Martinelli, et al.
Pageof 5